Concerned medical professionals gathered together and penned a singular letter to the FDA urging for a better gadolinium warning for patients. For years, the medical community has denied that there is an issue with the chemical gadolinium. This chemical agent is used in MRI or MRA scans as a contrasting agent. Many doctors are under the impression that the body naturally expels the chemical within a day of exposure. However, thousands still retain the chemical and are becoming ill. Now, many in the medical community are hoping the FDA pays attention and demands better warnings.
Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of elements in the periodic table called Lanthanides, the chemical is a rare earth element. Microwave applications, color TV tubes, synthetic gemstones, compact discs, and computer memory typically use the chemical. Also, the medical community uses this chemical element as an injectable contrast agent when patients undergo MRI or MRA scans.
The medical community believes that after they inject the body with this dye, it expels it naturally within a few hours. However, this is not always the case. The chemical agent can also stay in the body for months or years following a single imaging session. Therefore, it causes the body to develop a whole range of debilitating symptoms like brain fog, ligament tightening, balance problems, hair loss, cognitive symptoms and more.
New Gadolinium Warning
Many doctors in various fields concerned about gadolinium retention in the body banded together to write a letter to the FDA urging for a better gadolinium warning. The medical professionals point to a few facts in particular. First, since there is no consistent syndrome at the moment, it is hard for sufferers of symptoms of gadolinium retnetion to get recognition from the medical community. Plus, it is hard to prove the neurological effects. Many studies say there is a lack of them while studies rats. However, rats cannot express feelings like humans can.
The doctors also urged the FDA to look outside the brain for gadolinium retention. There could be interference with calcium channels, endocrine, and renal effects as well as the bone. To help diagnosis, doctors want the FDA to recommend including gadolinium exposure history in patient’s medical records. This is especially important for all patients presenting with unusual symptoms or disogased with diseases such as benign fasciculation syndrome, myokymia, small fiber neuropathy, fibromyalgia, etc. Hopefully, the FDA will heed this letter and help the thousands of people facing the horrible symptoms of gadolinium retention.
Free Case Evaluation
A gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have also over 20 years of experience helping consumers injured by unsafe products manufactured by large companies.